Clinical Trials Logo

Cardiovascular Diseases clinical trials

View clinical trials related to Cardiovascular Diseases.

Filter by:

NCT ID: NCT00200993 Completed - Obesity Clinical Trials

Peripheral Effects of Exercise on Cardiovascular Health (STRRIDE I)

Start date: September 1998
Phase: Phase 2
Study type: Interventional

To investigate the separate effects of the amount of exercise and exercise intensity on cardiovascular risk factors in overweight men and women with mild to moderate dyslipidemia.

NCT ID: NCT00200317 Completed - Clinical trials for Cardiovascular Disease

Interactive Technologies to Increase Exercise Behavior

Start date: February 2003
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to examine if an individually tailored Internet intervention is more efficacious than an individually tailored print-based intervention and standard Internet intervention for physical activity adoption and maintenance among sedentary adults.

NCT ID: NCT00200278 Completed - Clinical trials for Cardiovascular Disease

Exercise Instruction Via Phone or Print

Start date: August 2000
Phase: Phase 2
Study type: Interventional

The objective of this study is to determine the differential effect of intervention delivery channel (phone versus print versus wait list control) on physical activity adoption and maintenance in previously sedentary adults. Both delivery channels have been found to be effective, but telephone-based interventions require more commitment on the part of the subjects and are more labor intensive than print-based interventions. Thus, we will conduct a randomized controlled clinical trial comparing three groups: 1) telephone-based motivationally-tailored individualized feedback; 2) print-based, motivationally-tailored individualized feedback; 3) minimal contact waiting list control condition (receive intervention after 12 months as controls). Two hundred and twenty-eight healthy, sedentary women and men ages 18-65 will be randomly assigned to one of the two interventions or the waiting-list control condition. Our primary hypothesis is that individuals randomized to either phone or print conditions will exhibit significantly higher levels of physical activity participation at 6 and 12 months than individuals in the waiting list control condition. And, in addition, that subjects randomized to the telephone condition will exhibit significantly higher levels of physical activity participation at 6 and 12 months than those in the print condition.

NCT ID: NCT00192660 Completed - Clinical trials for Cardiovascular Disease

HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)

Start date: February 2003
Phase: Phase 4
Study type: Interventional

This is a prospective, non-randomised, 48 week study of the effect of protease inhibitor (PI) containing and non-PI containing antiretroviral regimens on the expression of adipocyte specific genes, protein levels and cellular structure in HIV-infected individuals, naive to therapy, who are starting therapy for the first time.

NCT ID: NCT00192621 Completed - HIV Infections Clinical Trials

Seronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kaletra and Combivir® in HIV-Negative Healthy Subjects

Start date: November 2004
Phase: Phase 4
Study type: Interventional

This is a randomised study of the effect of treatment with Combivir (zidovudine [AZT] and lamivudine [3TC]) and Kaletra (lopinavir [LPVr]), alone and in combination, on the development of abnormalities in lipid and glucose metabolism in HIV negative healthy subjects.

NCT ID: NCT00192543 Completed - Clinical trials for Cardiovascular Diseases

The Fish and Fruit Study: Trial of Fish and Fruit to Improve Survival of Aboriginal People With End Stage Renal Disease

Start date: May 2004
Phase: Phase 3
Study type: Interventional

Cardiovascular disease is the main cause of death in patients on dialysis for end stage renal disease. Omega-3 fatty acids and antioxidants have been shown to be protective in the general population. A diet of fish and fruit, which will provide the fatty acids and the antioxidants is being tried in dialysis patients to assess the effect on cardiovascular disease in this high risk group.

NCT ID: NCT00190593 Completed - Clinical trials for Cardiovascular Diseases

Raloxifene Use for The Heart

Start date: June 1998
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether raloxifene compared with placebo lowers the risk of coronary events and reduces the risk of invasive breast cancer in postmenopausal women at risk for major coronary events.

NCT ID: NCT00190580 Completed - Hypertension Clinical Trials

Kanagawa Valsartan Trial (KVT): Effects of Valsartan on Renal and Cardiovascular Disease

Start date: February 2003
Phase: Phase 4
Study type: Interventional

The purpose of this study is to prove the hypothesis that the progression of renal and cardiovascular disease is more efficiently prevented when the angiotensin II receptor blocker valsartan is added to conventional antihypertensive therapy.

NCT ID: NCT00190034 Suspended - Clinical trials for Cardiovascular Disease

Acetylcysteine Against Acute Renal Insult During Cardiopulmonary Bypass.

Start date: January 2005
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine whether N-acetylcysteine is effective in the prophylaxis of post-cardiopulmonary bypass acute renal impairment.

NCT ID: NCT00186706 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Selenium Supplementation in Chronic Obstructive Pulmonary Disease (COPD) Patients

Start date: September 2005
Phase: Phase 4
Study type: Interventional

Does an oral selenium supplement increase blood levels of antioxidants in patients with established, smoking-related lung disease? Members of our study group recently discovered that elevated levels of the anti-oxidant GPx-1 may be protective against heart disease. We are studying whether selenium supplementation will improve GPx-1 levels.